Peter Riebling

Peter Riebling has a comprehensive work experience in the pharmaceutical industry, with expertise in medical and scientific communications, clinical sciences, regulatory affairs, and medical writing. Peter is currently serving as the Executive Director of Medical and Scientific Communications at Solve Therapeutics, Inc. Prior to their current role, they held the same position at VelosBio Inc. from September 2019 to June 2021. Before that, they worked as the Senior Director of Clinical Sciences at Nevakar Inc. from November 2017 to September 2019.

Peter has also held various positions at PTC Therapeutics, Inc., starting as an Associate Director of Medical Writing from March 2014 to July 2015, then as the Director of Clinical Sciences from July 2015 to June 2016, and later as the Senior Director of Clinical Sciences from June 2016 to November 2017.

Earlier in their career, Peter worked as the Manager of Medical Writing at Daiichi Sankyo from July 2012 to March 2014 and as an Associate Director of Regulatory and Medical Writing at PTC Therapeutics from October 2007 to July 2012.

Peter's career in the pharmaceutical industry began in 2005 as a Senior Regulatory Affairs Associate at Strides Inc.Overall, Peter Riebling has amassed considerable experience and expertise in the medical and scientific communications, clinical sciences, regulatory affairs, and medical writing fields throughout their career.

Peter Riebling has a Bachelor of Arts (B.A.) degree in English/Creative Writing from Emory University. Peter also holds a Master of Fine Arts (M.F.A.) degree in Creative Writing from George Mason University and a Master of Science (M.S.) degree in Biotechnology Studies from the University of Maryland Global Campus. In addition to their degrees, Peter has obtained a Certificate of Biostatistics from the University of California-San Diego and is certified in Regulatory Affairs by the Regulatory Affairs Professional Society.